Jazz Pharmaceuticals
JAZZ
#2007
Rank
S$12.70 B
Marketcap
S$209.06
Share price
0.31%
Change (1 day)
25.27%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -S$0.89 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are S$4.15 Billion. In 2024 the company made an earning of S$0.59 Billion, an increase over its 2023 earnings that were of S$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.89 Billion-248.79%
2024 S$0.59 B57.87%
2023 S$0.37 B-179.92%
2022 -S$0.48 Billion230.37%
2021 -S$0.15 Billion-141.02%
2020 S$0.34 B-39.45%
2019 S$0.57 B-14.2%
2018 S$0.67 B20.03%
2017 S$0.56 B-17.15%
2016 S$0.67 B22.14%
2015 S$0.55 B187.64%
2014 S$0.19 B-50.79%
2013 S$0.39 B73.63%
2012 S$0.22 B41.69%
2011 S$0.15 B116.61%
2010 S$73.44 M262.77%
2009 S$20.24 M-111.33%
2008 -S$0.18 Billion1.31%
2007 -S$0.18 Billion77.8%
2006 -S$99.21 Million36.59%
2005 -S$72.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.86 B-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
S$2.66 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-S$3.05 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
S$2.25 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel